Program Schedule

161
Managing HIV Toxicity and Drug Resistance

Saturday, October 11, 2014: 7:00 AM-8:15 AM
Room: The Pennsylvania Convention Center: 119-AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss viral resistance and resistance testing for patients with HIV
  • describe the importance of considering vital resistance in the selection of antiretroviral therapy
  • outline the importance of assessing and addressing the adverse effects of antiretroviral drug toxicity

Target Audience: Public health practitioners, Members-in-training, Infectious diseases physicians, HIV specialists, HIV clinicians, Fellows, Clinicians

Tracks: HIV-STD-TB

Meet-the-professors:  Athe Tsibris, MD, MS, Brigham and Women's Hospital and Roger Bedimo, MD, University of Texas Southwestern Medical School

Presentations:
7:30 AM

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-135-L02-P

Disclosures:

A. Tsibris, None

R. Bedimo, Merck & Co.: Grant Investigator and Scientific Advisor, Consulting fee, Grant recipient and Research grant
Bristol Myers Squibb: Grant Investigator and Scientific Advisor, Consulting fee, Grant recipient and Research grant
ViiV Healthcare: Scientific Advisor, Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek